Bharat Biotech is all set to begin phase II and III clinical trials for Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, reports The Economic Times quoting VK Paul, Member (Health), Niti Aayog on Tuesday. "Covaxin has been approved by the Drugs
